Literature DB >> 12562640

Chemotherapy in gastric cancer: a never ending saga.

A D Roth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562640     DOI: 10.1093/annonc/mdg081

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG50) of gastric carcinoma.

Authors:  Vahid Bagheri; Mehran Gholamin; Atena Mansouri; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

2.  Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.

Authors:  Da-Qiang Li; Zhi-Biao Wang; Jin Bai; Jie Zhao; Yuan Wang; Kai Hu; Yong-Hong Du
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

3.  HDM2 regulation by AURKA promotes cell survival in gastric cancer.

Authors:  Vikas Sehdev; Ahmed Katsha; Janet Arras; Dunfa Peng; Mohammed Soutto; Jeffrey Ecsedy; Alexander Zaika; Abbes Belkhiri; Wael El-Rifai
Journal:  Clin Cancer Res       Date:  2013-11-15       Impact factor: 12.531

4.  FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma.

Authors:  Mao-Ran Li; Chun-Chao Zhu; Tian-Long Ling; Ye-Qian Zhang; Jia Xu; En-Hao Zhao; Gang Zhao
Journal:  BMC Gastroenterol       Date:  2017-05-02       Impact factor: 3.067

5.  The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance.

Authors:  Mitsuyoshi Okazaki; Sachio Fushida; Tomoya Tsukada; Jun Kinoshita; Katsunobu Oyama; Tomoharu Miyashita; Itasu Ninomiya; Shinichi Harada; Tetsuo Ohta
Journal:  Cancer Manag Res       Date:  2018-07-04       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.